• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个针对BRCA突变携带者的专门随访诊所。

A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.

作者信息

Yerushalmi Rinat, Rizel Shulamith, Zoref Dalia, Sharon Eran, Eitan Ram, Sabah Gad, Grubstein Ahuva, Rafson Yael, Cohen Maya, Magen Ada, Birenboim Iehudit, Margel David, Ozlavo Rachel, Sulkes Aaron, Brenner Baruch, Perry Shlomit

机构信息

Institute of Oncology, Davidoff Center.

Division of Surgery, Hospital for Women, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

出版信息

Isr Med Assoc J. 2016 Sep;18(9):549-552.

PMID:28471604
Abstract

Women who carry the BRCA gene mutation have an up to 80% chance of developing cancer, primarily of breast and ovarian origin. Confirmation of carrier status is described by many women as an overwhelming, life-changing event. Healthy individuals harboring a BRCA mutation constitute a high risk population with unique needs, often overlooked by health authorities. As such, we felt the need to create a specialized service dedicated specifically to this high risk population. The clinic staff comprises an experienced multidisciplinary team of health professionals who can support the medical and emotional needs of this population. Since its inception in 2001 the clinic has served 318 women. The mean age of patients is 46 years. With a median follow-up of 46 months, 21 women have developed malignancies, including 17 breast cancers, 1 ovarian cancer and 3 additional cancers. All but one of the patients above the age of 40 underwent bilateral salpingo-oophorectomy (BSO). The median and mean ages at BSO were 46.5 and 48 years, respectively (range 33-68). However, only 28.3% underwent bilateral preventive mastectomy. A multidisciplinary clinic for BRCA mutation carriers provides a "home" for this unique population with unmet needs. The high rate of BSO in women before natural menopause indicates that both the medical community and this population are aware of international guidelines supporting this procedure. We believe that a dedicated clinic, with a multidisciplinary team, is likely to contribute to the health, quality of life and survival of BRCA carriers.

摘要

携带BRCA基因突变的女性患癌几率高达80%,主要是乳腺癌和卵巢癌。许多女性称,确认携带该基因突变的状态是一件极具震撼力、改变人生的大事。携带BRCA基因突变的健康个体构成了一个有独特需求的高危人群,而这些需求往往被卫生当局忽视。因此,我们觉得有必要专门为这一高危人群创建一项特殊服务。该诊所的工作人员由经验丰富的多学科健康专业团队组成,他们能够满足这一人群的医疗和情感需求。自2001年成立以来,该诊所已为318名女性提供了服务。患者的平均年龄为46岁。中位随访时间为46个月,有21名女性患上了恶性肿瘤,其中包括17例乳腺癌、1例卵巢癌和3例其他癌症。除一名患者外,所有40岁以上的患者都接受了双侧输卵管卵巢切除术(BSO)。接受BSO手术的中位年龄和平均年龄分别为46.5岁和48岁(范围为33 - 68岁)。然而,只有28.3%的人接受了双侧预防性乳房切除术。为携带BRCA基因突变者设立的多学科诊所为这一有未满足需求的独特人群提供了一个“家”。自然绝经前女性中BSO手术的高比例表明,医学界和这一人群都了解支持该手术的国际指南。我们相信,一个配备多学科团队的专门诊所可能有助于提高携带BRCA基因者的健康水平、生活质量和生存率。

相似文献

1
A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.一个针对BRCA突变携带者的专门随访诊所。
Isr Med Assoc J. 2016 Sep;18(9):549-552.
2
Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.预防性输卵管切除术和延迟卵巢切除术作为 BRCA 基因突变携带者的替代方案。
Obstet Gynecol. 2013 Jan;121(1):14-24. doi: 10.1097/aog.0b013e3182783c2f.
3
[Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers].[BRCA 突变携带者乳腺癌和卵巢癌的手术预防方法]
Vopr Onkol. 2013;59(2):5-11.
4
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.预防性降低风险的输卵管卵巢切除术在 BRCA 基因突变携带者中的满意度非常高,且与手术时患者的特征相关性很小:一项前瞻性研究。
Menopause. 2021 Feb 1;28(3):263-270. doi: 10.1097/GME.0000000000001737.
5
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者乳腺癌术后卵巢切除术对生存的影响。
JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658.
6
Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.BRCA1/2 基因突变携带者的监测和预防策略的成本效益分析。
Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
7
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.早期输卵管切除术(输卵管切除)联合延迟卵巢切除术以改善生活质量,作为BRCA1/2突变携带者降低风险的输卵管卵巢切除术的替代方案(TUBA研究):一项前瞻性非随机多中心研究。
BMC Cancer. 2015 Aug 19;15:593. doi: 10.1186/s12885-015-1597-y.
8
Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.比较BRCA1和BRCA2基因突变携带者乳腺癌患者行同步与序贯输卵管卵巢切除术的情况。
Clin Breast Cancer. 2016 Dec;16(6):494-499. doi: 10.1016/j.clbc.2016.06.016. Epub 2016 Jul 5.
9
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.携带 BRCA1 或 BRCA2 种系突变的 158 名法国队列妇女的乳腺癌和卵巢癌风险管理:患者选择和结局。
Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1.
10
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.接受BRCA1和BRCA2检测的女性临床特征与风险降低干预措施之间的关联:一项单机构研究。
Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352.

引用本文的文献

1
Development of a person-centred digital platform for the long-term support of people living with an adult-onset genetic disease predisposition: a mixed-methods study protocol.以患者为中心的数字平台用于为成年发病遗传疾病倾向者提供长期支持的开发:一项混合方法研究方案。
BMJ Open. 2023 Jul 30;13(7):e071492. doi: 10.1136/bmjopen-2022-071492.
2
GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer.基因家 - 为有癌症遗传倾向的个体提供护理的新模式。
Cancer Control. 2022 Jan-Dec;29:10732748221109951. doi: 10.1177/10732748221109951.
3
Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016.
遗传性卵巢癌风险降低:2006 年至 2016 年期间,对区域遗传性妇科癌症诊所患者观点和服务提供情况的回顾性评估。
BMC Womens Health. 2022 Jun 29;22(1):263. doi: 10.1186/s12905-022-01844-5.
4
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.50 岁及以上女性 BRCA 基因突变携带者乳房活检转诊率:回顾性对比研究和匹配分析。
Breast Cancer Res Treat. 2022 Jun;193(2):507-514. doi: 10.1007/s10549-021-06498-9. Epub 2022 Apr 7.
5
Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis.BRCA突变与子宫内膜癌之间的关联:一项荟萃分析的系统评价
Arch Gynecol Obstet. 2021 Jun;303(6):1569-1579. doi: 10.1007/s00404-020-05887-7. Epub 2020 Nov 20.
6
Management of ovarian cancer risk in women with pathogenic variants.携带致病变异的女性卵巢癌风险管理。
CMAJ. 2019 Aug 12;191(32):E886-E893. doi: 10.1503/cmaj.190281.